Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary EmbolismCompleted
NCT00413374NAUpdated Jun 28, 2018
Sponsor: Brigham and Women's Hospital
Deep Vein Thrombosis · Pulmonary Embolism
United States
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaCompleted
NCT00132301Phase 3Updated Jun 25, 2018
Sponsor: VA Office of Research and Development
Prostate Cancer
United States, Puerto Rico
Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) PatientsCompleted
NCT02411825Phase 1Updated Jun 15, 2018
Sponsor: Sanofi
Type 2 Diabetes Mellitus
Germany
Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced HyperglycemiaCompleted
NCT01184014Phase 4Updated Jun 13, 2018
Sponsor: HealthPartners Institute
Hyperglycemia
United States
PACT (Platelet Activity After Clopidogrel Termination)Completed
NCT00619073NAUpdated May 31, 2018
Sponsor: University of Massachusetts, Worcester
Blood Platelets · Clopidogrel
United States
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:Completed
NCT02890121N/AUpdated May 23, 2018
Sponsor: Fundación Pública Andaluza Progreso y Salud
Systemic Autoimmune Diseases
Austria, Belgium, France, Germany, Hungary +4 more
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-controlCompleted
NCT02890147N/AUpdated May 23, 2018
Sponsor: Fundación Pública Andaluza Progreso y Salud
Healthy Subjects
Austria, Belgium, France, Germany, Hungary +4 more
Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial DiseaseCompleted
NCT00443287Phase 2Updated May 17, 2018
Sponsor: Sanofi
Intermittent Claudication
United States, Austria, Canada, France, Poland +2 more
Phase 1 Safety Testing of SAR405838Completed
NCT01636479Phase 1Updated May 17, 2018
Sponsor: Sanofi
Neoplasm Malignant
United States, France, Netherlands
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)Completed
NCT02585778Phase 3Updated May 17, 2018
Sponsor: Sanofi
Hypercholesterolaemia
United States, Austria, Belgium, France, Germany +5 more
The Belgian Diabetes in Pregnancy Study: BEDIP-N StudyCompleted
NCT02036619N/AUpdated May 11, 2018
Sponsor: Universitaire Ziekenhuizen KU Leuven
Gestational Diabetes · Diabetes
Belgium
Efficacy and Tolerability of ZD6474 in Patients With Thyroid CancerCompleted
NCT00098345Phase 2Updated May 7, 2018
Sponsor: Genzyme, a Sanofi Company
Thyroid Cancer
United States, France
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseCompleted
NCT01308242EARLY_Phase 1Updated May 2, 2018
Sponsor: Milton S. Hershey Medical Center
Chronic Kidney Disease
United States
Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck CancerTerminated
NCT00256308Phase 2Updated May 1, 2018
Sponsor: University of California, Irvine
Head and Neck Cancer
United States
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)Completed
NCT02642159Phase 4Updated May 1, 2018
Sponsor: Sanofi
Dyslipidemia
United States, Australia, Brazil, Finland, Germany +10 more
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompleted
NCT00142480Phase 2Updated Apr 25, 2018
Sponsor: Massachusetts General Hospital
Biliary Tract Cancer · Gallbladder Adenocarcinoma
United States
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCompleted
NCT00256113Phase 3Updated Apr 20, 2018
Sponsor: Sanofi
Depressive Disorder
Canada, Chile, Croatia, Czechia, Estonia +3 more
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompleted
NCT01662921Phase 2Updated Apr 18, 2018
Sponsor: Sansum Diabetes Research Institute
Diabetes During Pregnancy
United States
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenCompleted
NCT01571284Phase 3Updated Apr 17, 2018
Sponsor: Sanofi
Colorectal Cancer Metastatic
United States, Belgium, Brazil, Canada, Chile +18 more
Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed InfantsCompleted
NCT01861730Phase 1, Phase 2Updated Apr 9, 2018
Sponsor: Aeras
Tuberculosis
South Africa
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast CancerCompleted
NCT00689156Phase 3Updated Apr 5, 2018
Sponsor: Danish Breast Cancer Cooperative Group
Breast Neoplasms
Denmark
Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVTCompleted
NCT00585182Phase 4Updated Apr 5, 2018
Sponsor: University of Utah
Obesity · Venous Thrombosis · Anticoagulants
United States
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal AdenocarcinomaCompleted
NCT01757171Phase 2Updated Apr 3, 2018
Sponsor: Weill Medical College of Cornell University
Gastric Adenocarcinoma · Gastroesophageal Adenocarcinoma · Distal Esophageal Adenocarcinoma
United States
Effects of Thymoglobulin on Human B CellsWithdrawn
NCT02137876N/AUpdated Mar 29, 2018
Sponsor: Northwestern University
Acute Humoral Rejections · Chronic Humoral Rejections · Transplant
United States
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCompleted
NCT02434822Phase 3Updated Mar 26, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Cholera
Dominican Republic

Previous page Next page